MeSH Browser

MeSH Supplementary: AML92 protocol
Unique ID: C107288
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C107288
Registry Numbers: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cytarabine / analogs & derivatives; Daunorubicin; Tretinoin
Frequency: 3
Note: chemotherapy protocol consisting of enocitabine, all-trans retinoic acid, and daunorubicin; used against acute promyelocytic leukemia
Source: Blood 1995 Mar 1;85(5):1202-6
Date of Entry: 1997/08/19
Revision Date: 2013/11/06

AML92 protocol MeSH Supplementary Concept Data 2025